Induction of an in vitro reversible hypometabolism through chitosan-based nanoparticles

References

• Ayre M, Zancanaro C, Malatesta M. Morpheus-hypometabolic stasis in humans for long term space flight. J Brit Interplan Soc 2004; 57: 325–39
   Google Scholar
• Baldelli B, Vecchio L, Biggiogera M, Vittoria E, Muzzonigro G, Gazzanelli G, Malatesta M. Ultrastructural and immunocytochemical analyses of opioid treatment effects on PC3 prostatic cancer cells. Microsc Res Tech 2004; 64: 243–9
   PubMed Web of Science ®Google Scholar
• Baldelli B, Vecchio L, Bottone MG, Muzzonigro G, Biggiogera M, Malatesta M. The effect of the enkephalin DADLE on transcription does not depend on opioid receptors. Histochem Cell Biol 2006; 126: 189–97
   PubMed Web of Science ®Google Scholar
• Baldrick P. The safety of chitosan as a pharmaceutical excipient. Regul Toxicol Pharm 2010; 56: 290–9
   PubMed Web of Science ®Google Scholar
• Béduneau A, Saulnier P, Benoit JP. Active targeting of brain tumors using nanocarriers. Biomaterials 2007; 28: 4947–67
   PubMed Web of Science ®Google Scholar
• Belcheva M, Barg J, Rowinski J, Clark WG, Gloeckner CA, Ho A, Gao XM, Chuang DM, Coscia C. Novel opioid binding sites associated with nuclei of NG 108-15 neurohybrid cells. J Neurosci 1993; 13: 104–14
   PubMed Web of Science ®Google Scholar
• Benedict PE, Benedict MB, Su TP, Bolling SF. Opiate drugs and delta-receptor-mediated myocardial protection. Circulation 1999; 100: 357–60
   Web of Science ®Google Scholar
• Bernhard W. A new staining procedure for electron microscopical cytology. J Ultrastruct Res 1969; 27: 250–65
   PubMedGoogle Scholar
• Bolling SF, Benedict MB, Tramontini NL, Kilgore KS, Harlow HJ, Su TP, Oeltgen PR. Hibernation trigger and myocardial protection. Circulation 1998; 98: 220–3
   Web of Science ®Google Scholar
• Bolling K, Halldorsson A, Allen BS, Rahman S, Wang T, Kronon M, Feinberg H. Prevention of the hypoxic reoxygenation injury with the use of a leukocyte-depleting filter. J Thorac Cardiovasc Surg 1997a; 113: 1081–9
   PubMed Web of Science ®Google Scholar
• Bolling K, Kronon M, Allen BS, Wang T, Ramon S, Feinberg H. Myocardial protection in normal and hypoxically stressed neonatal hearts: The superiority of blood versus crystalloid cardioplegia. J Thorac Cardiovasc Surg 1997b; 113: 994–1003
   PubMed Web of Science ®Google Scholar
• Borlongan CV, Hayashi T, Oeltgen PR, Su TP, Wang Y. Hibernation-like state induced by an opioid peptide protects against experimental stroke. BMC Biol 2009; 7: 31–40
   PubMed Web of Science ®Google Scholar
• Chen Y, Siddalingappa B, Chan PHH, Benson HAE. Development of a chitosan-based nanoparticle formulation for delivery of hydrophilic hexapeptide, dalargin. J Pept Sci 2008; 90: 663–70
   Web of Science ®Google Scholar
• Chien SF, Oeltgen PR, Diana JN, Salley RK, Su TP. Extension of tissuesurvival time in multiorgan block preparation using a delta opioid DADLE. J Thorac Cardiovasc Surg 1994; 107: 964–7
   PubMed Web of Science ®Google Scholar
• Colonna C, Conti B, Perugini P, Pavanetto F, Modena T, Dorati R, Genta I. Chitosan glutamate nanoparticles for protein delivery: Development and effect on prolidase stability. J Microencapsul 2007a; 24: 553–64
   PubMed Web of Science ®Google Scholar
• Colonna C, Conti B, Perugini P, Pavanetto F, Modena T, Dorati R, Iadarola P, Genta I. Site-directed PEGylation as successful approach to improve the enzyme replacement therapy in the case of prolidase. Int J Pharm 2007b; 358: 230–7
   Google Scholar
• Cupo A, Conrath M, Eybalin M, Fourrier O, Zouaoui D, Kadly P, Herbrecht F. Monoclonal antiidiotypic antibodies against delta opioid receptors as an electron microscope probe. Eur J Cell Biol 1992; 113: 181–7
   Google Scholar
• Elsabee MZ, Morsi RE, Al-Sabagh AM. Surface active properties of chitosan and its derivatives. Colloids Surf B 2009; 74: 1–16
   PubMed Web of Science ®Google Scholar
• Fakan S. Ultrastructural cytochemical analyses of nuclear functional architecture. Eur J Histochem 2004; 48: 5–14
   PubMed Web of Science ®Google Scholar
• Farahidah M, Van der Walle CF. Engineering biodegradable polyester particles with specific drug targeting and drug release properties. J Pharm Sci 2008; 97: 71–87
   PubMed Web of Science ®Google Scholar
• Garcia-Garcia E, Andrieux K, Gil S, Couvreur P. Colloidal carriers and blood-brain barrier (BBB) translocation: A way to deliver drugs to the brain?. Int J Pharm 2005; 298: 274–92
   PubMed Web of Science ®Google Scholar
• Genta I, Colonna C, Perugini P, Pavanetto F, Modena T, Valli M, Muzzarelli C, Conti B. Evaluation of bioadhesive performance of chitosan derivatives as films for buccal application. J Drug Delivery Sci Tech 2005; 16: 459–63
   Google Scholar
• Horton ND, Kaftani DJ, Bruce DS, Bailey EC, Krober AS, Jones JR, Turker M, Khattar N, Su TP, Bolling SF, et al. Isolation and partial characterization of an opioid-like 88 kDa hibernation related protein. Comp Biochem Physiol B Biochem Mol Biol 1998; 119: 787–805
   PubMed Web of Science ®Google Scholar
• Jallouli Y, Paillard A, Chang J, Sevin E, Betbeder D. Influence of surface charge and inner composition of porous nanoparticles to cross blood–brain barrier in vitro. Int J Pharm 2007; 344: 103–9
   PubMed Web of Science ®Google Scholar
• Kampa M, Bakogeorgou E, Hatzoglou A, Damianaki A, Martin PM, Castanas E. Opioid alkaloids and casomorphin peptides decrease the proliferation of prostatic cancer cell lines (LNCaP, PC3 and DU145) through a partial interaction with opioid receptors. Eur J Pharmacol 1997; 335: 255–65
   PubMed Web of Science ®Google Scholar
• Kean T, Thanou M. Biodegradation, biodistribution and toxicity of chitosan. Adv Drug Delivery Rev 2010; 62: 3–11
   PubMed Web of Science ®Google Scholar
• Kreuter J. Nanoparticles—a historical perspective. Int J Pharm 2007; 331: 1–10
   PubMed Web of Science ®Google Scholar
• Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B 2010; 75: 1–18
   PubMed Web of Science ®Google Scholar
• Lee CC. Is human hibernation possible?. Annu Rev Med 2008; 59: 177–86
   PubMed Web of Science ®Google Scholar
• Liu Z, Jiao Y, Wang Y, Zhou C, Zhang Z. Polysaccharides-based nanoparticles as drug delivery systems. Adv Drug Delivery Rev 2008; 60: 1650–62
   PubMed Web of Science ®Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55–63
   PubMed Web of Science ®Google Scholar
• Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. J Controlled Release 2008; 125: 193–209
   PubMed Web of Science ®Google Scholar
• Oeltgen PR, Horton ND, Bolling SF, Su TP. Extended lung preservation with the use of hibernation trigger factors. Ann Thorac Surg 1996; 61: 1488–93
   PubMed Web of Science ®Google Scholar
• Overington JP, Al-Lazikani B, Hopkins AL. How many drug targets are there?. Nat Rev Drug Discovery 2006; 5: 993–6
   PubMed Web of Science ®Google Scholar
• Park JH, Savaranakumar G, Kim K, Kwon IC. Targeted delivery of low molecular drugs using chitosan and its derivatives. Adv Drug Delivery Rev 2010; 62: 28–41
   PubMed Web of Science ®Google Scholar
• Peppas NA, Huang Y. Nanoscale tecnology of mucoadhesive interactions. Adv Drug Delivery Rev 2004; 56: 1675–87
   PubMed Web of Science ®Google Scholar
• Su TP. Delta opioid peptide[D-Ala(2),D- Leu(5)]enkephalin promotes cell survival. J Biomed Sci 2000; 7: 195–9
   PubMed Web of Science ®Google Scholar
• Vecchio L, Soldani C, Bottone MG, Malatesta M, Martin TE, Rothblum LI, Pellicciari C, Biggiogera M. DADLE induces a reversible hibernation-like state in HeLa cells. Histochem Cell Biol 2006; 125: 193–201
   PubMed Web of Science ®Google Scholar
• Wadhwa S, Paliwal R, Paliwal SR, Vyas SP. Chitosan and its role in ocular therapeutics. Mini Rev Med Chem 2009; 9: 1639–47
   PubMed Web of Science ®Google Scholar
• Wu Y, Yang W, Wang C, Hu J, Fu S. Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate. Int J Pharm 2005; 295: 235–45
   PubMed Web of Science ®Google Scholar
• Yang Y, Xia X, Zhang Y, Wang Q, Li L, Luo G, Xia Y. Delta-opioid receptor activation attenuates oxidative injury in the ischemic rat brain. BMC Biol 2009; 7: 55–63
   PubMed Web of Science ®Google Scholar
• Yin H, Du Y, Zhang J. Low molecular weight and oligomeric chitosans and their bioactivities. Curr Top Med Chem 2009; 9: 1546–59
   PubMed Web of Science ®Google Scholar
• Zhu M, Li MW, Tian XS, Ou XM, Zhu CQ, Guo JC. Neuroprotective role of delta-opioid receptors against mitochondrial respiratory chain injury. J Brain Res 2009; 1252: 183–91
   Google Scholar